Search results
Novartis (NVS) Plans to Spin Off Generics Business Sandoz
Zacks via Yahoo Finance· 2 years agoNovartis NVS has announced plans to spin off Sandoz, its generics and biosimilars division, into a...
Pharma giant Novartis sees shares jump after strong Q1
dpa international via Yahoo Finance· 3 weeks agoSwiss pharmaceutical giant Novartis saw its shares jump after reporting solid first-quarter profits...
German regulators approve Novartis deal to buy drugmaker Morphosys
dpa international via Yahoo News· 2 months agoGerman antitrust regulators have approved the takeover of German biotech company Morphosys by the...
Novartis (NVS) to Focus on US Markets Backed by 8 Key Drugs
Zacks via Yahoo Finance· 2 years agoNovartis (NVS) unveils a new focused strategy with the spotlight on the US markets driven by eight...
East Hanover pharma company to lay off over 100 employees this fall
The Bergen Record via Yahoo Finance· 9 months agoSwiss drugmaker Novartis is laying off 103 employees at its U.S headquarters in Morris County, the...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
Novartis to cut 680 jobs in product development
Reuters via Yahoo Finance· 1 month agoNovartis is to cut up to 680 jobs in its development organisation, which helps bring its drugs to market, the Swiss pharmaceuticals company said on...
The Zacks Analyst Blog Highlights Novartis, J&J, AbbVie, Merck and Pfizer
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 29, 2022 – Zacks.com announces the list of stocks...
Novartis to spin off generics business Sandoz next year
Reuters via Yahoo Finance· 2 years agoZURICH/LONDON (Reuters) -Novartis plans to spin off its underperforming generics unit Sandoz to...
Novartis updates mid-term outlook as Q4 profit up
dpa international via Yahoo News· 3 months agoSwiss pharma major Novartis on Wednesday updated its mid-term guidance as it reported a fourth-quarter net income of $8.48 billion, up from last year's...
